223 related articles for article (PubMed ID: 31520213)
41. Pelvic exenteration for primary and recurrent gynaecological malignancies.
de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
[TBL] [Abstract][Full Text] [Related]
42. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity.
Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D
Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571
[TBL] [Abstract][Full Text] [Related]
43. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
Puntambekar S; Kudchadkar RJ; Gurjar AM; Sathe RM; Chaudhari YC; Agarwal GA; Rayate NV
Gynecol Oncol; 2006 Sep; 102(3):513-6. PubMed ID: 16510172
[TBL] [Abstract][Full Text] [Related]
44. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
[TBL] [Abstract][Full Text] [Related]
45. Curative pelvic exenteration: initial experience and clinical outcome.
Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
[TBL] [Abstract][Full Text] [Related]
46. Anatomical approaches in locally advanced and recurrent pelvic malignancy.
Collins D; Jones R; Griffiths B
Eur J Surg Oncol; 2022 Nov; 48(11):2258-2262. PubMed ID: 35086682
[TBL] [Abstract][Full Text] [Related]
47. [Pelvic exenteration--indications, radical nature and follow-up demonstrated with 33 clinical cases].
Kolbert G; Müller G; Kujath P; Bruch HP
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1096-7. PubMed ID: 9574344
[TBL] [Abstract][Full Text] [Related]
48. Total pelvic exenteration for locally advanced rectal cancer.
Law WL; Chu KW; Choi HK
J Am Coll Surg; 2000 Jan; 190(1):78-83. PubMed ID: 10625236
[TBL] [Abstract][Full Text] [Related]
49. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
[No Abstract] [Full Text] [Related]
50. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes?
Colibaseanu DT; Dozois EJ; Mathis KL; Rose PS; Ugarte ML; Abdelsattar ZM; Williams MD; Larson DW
Dis Colon Rectum; 2014 Jan; 57(1):47-55. PubMed ID: 24316945
[TBL] [Abstract][Full Text] [Related]
51. Urological outcomes following pelvic exenteration for advanced pelvic cancer are not inferior to those following radical cystectomy.
Aslim EJ; Chew MH; Chew GK; Lee LS
ANZ J Surg; 2018 Sep; 88(9):896-900. PubMed ID: 29895098
[TBL] [Abstract][Full Text] [Related]
52. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
[TBL] [Abstract][Full Text] [Related]
53. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
[TBL] [Abstract][Full Text] [Related]
54. Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer.
Soeda S; Furukawa S; Sato T; Ueda M; Kamo N; Endo Y; Kojima M; Nomura S; Kataoka M; Fujita S; Endo H; Takahashi T; Watanabe T; Yamada H; Fujimori K
Anticancer Res; 2019 Oct; 39(10):5631-5637. PubMed ID: 31570460
[TBL] [Abstract][Full Text] [Related]
55. Outcomes following repeat exenteration for locally advanced pelvic malignancy.
Blake J; Koh CE; Steffens D; De Robles MS; Brown K; Lee P; Austin K; Solomon MJ
Colorectal Dis; 2021 Mar; 23(3):646-652. PubMed ID: 33058495
[TBL] [Abstract][Full Text] [Related]
56. Intraoperative pelvic brachytherapy for treatment of locally advanced or recurrent colorectal cancer.
Turley RS; Czito BG; Haney JC; Tyler DS; Mantyh CR; Migaly J
Tech Coloproctol; 2013 Feb; 17(1):95-100. PubMed ID: 22986843
[TBL] [Abstract][Full Text] [Related]
57. [Quality of life after extensive pelvic surgery].
Levý M; Lipská L; Visokai V; Šimša J
Rozhl Chir; 2016; 95(9):358-462. PubMed ID: 27653304
[TBL] [Abstract][Full Text] [Related]
58. Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: A 9 year consecutive single-centre cohort study.
Katory M; McLean R; Paez E; Kucukmetin A; Naik R
Int J Surg; 2017 Jul; 43():38-45. PubMed ID: 28529192
[TBL] [Abstract][Full Text] [Related]
59. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
[TBL] [Abstract][Full Text] [Related]
60. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
